Matthew Perrone, KKTV 11 News

Matthew Perrone

KKTV 11 News

Washington, DC, United States

Contact Matthew

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Unknown
Past:
  • KKTV 11 News

Past articles by Matthew:

Sleep apnea device recall drags on, stoking anger from users

Sound-dampening foam in the pressurized breathing machines can break down over time, leading users to potentially inhale tiny black particles or hazardous chemicals while they sleep, manufacturer Philips warned. → Read More

Tweaked COVID boosters in US must target newer omicron types

Pfizer and Moderna already were brewing and testing boosters updated against the first omicron mutant in anticipation of an October rollout. → Read More

FDA orders all Juul electronic cigarettes removed from US market

The action is part of a sweeping effort by the Food and Drug Administration to bring scientific scrutiny to the multibillion-dollar vaping industry after years of regulatory delays. → Read More

Abbott restarts baby formula plant linked to contamination

The February shutdown of the largest formula factory in the country led to supply problems. → Read More

FDA chief to detail delays inspecting baby formula plant

FDA Commissioner Robert Califf is set to answer questions Wednesday from House lawmakers probing the events leading to the formula shortage. → Read More

Biden offers logistics support to ease formula shortage

President Joe Biden is offering formula manufacturers and retailers transportation and logistics support to ease the nationwide shortage of baby formula. → Read More

EXPLAINER: What’s behind the baby formula shortage?

Many parents are hunting for infant formula after a combination of short- and long-term problems hit most of the biggest U.S. brands. → Read More

E-cigs using synthetic nicotine come under FDA oversight

Under a law taking effect Thursday, the Food and Drug Administration can regulate e-cigarettes and similar products that use synthetic nicotine. → Read More

Moderna vaccine fully approved, company announces

The action by the Food and Drug Administration means the agency has completed the same rigorous, time-consuming review of Moderna’s shot as dozens of other long-established vaccines. → Read More

US begins offering 1 billion free COVID tests, but many more needed

The website, COVIDTests.gov, allows people to order four at-home tests per household and have them delivered by mail. But the tests won’t arrive for seven to 12 days. → Read More

Omicron may sideline two leading drugs against COVID-19

The rapidly-spreading omicron variant may soon leave U.S. doctors without two of the standard treatments they’ve used to fight COVID-19. → Read More

Pfizer confirms COVID pill’s results, potency versus omicron

Pfizer says that its experimental COVID-19 pill appears effective against the omicron variant. → Read More

FDA expands Pfizer COVID-19 booster to people as young as 16

On Thursday, the Food and Drug Administration gave emergency authorization for 16- and 17-year-olds to get a third dose of the vaccine made by Pfizer and its partner BioNTech -- if it’s been six months since their last shot. → Read More

US OKs new COVID-19 antibody drug for high-risk patients

The drug could benefit cancer patients, organ transplant recipients and people with severe allergies to vaccinations. → Read More

Final US hurdle for Merck’s COVID-19 pill: FDA panel review

The Food and Drug Administration is asking its outside experts whether the agency should authorize the pill, weighing new information that it is less effective than first reported and may cause birth defects. → Read More

FDA expands COVID boosters to all adults, final hurdle ahead

Pfizer and Moderna announced Friday the Food and Drug Administration’s decision after at least 10 states already had started offering boosters to all adults. → Read More

Pfizer says COVID-19 pill cut hospital, death risk by 90%

Pfizer said it will ask the FDA and international regulators to authorize its pill as soon as possible, after independent experts recommended halting the company’s study based on the strength of its results. Once Pfizer applies, the FDA could make a decision within weeks or months. → Read More

Pfizer says COVID-19 vaccine more than 90% effective in kids

Details of the study were posted online Friday as U.S. regulators consider opening vaccinations to youngsters 5 to 11. → Read More

FDA official: Booster announcements coming Wednesday

The FDA’s Doran Fink previewed “some announcements later today,” which were expected to include allowing the mixing and matching of COVID-19 booster doses among the three U.S. manufacturers — Pfizer, Moderna and J&J. Fink appeared at a meeting of vaccine experts convened by the Centers for Disease Control and Prevention, who are expected to take up the FDA decisions and make their own… → Read More

FDA panel endorses booster shot for J&J COVID-19 vaccine

The FDA will use its advisers’ recommendations to decide whether to authorize boosters for both J&J and Moderna, after which another government agency will rule on who should roll up their sleeves. → Read More